DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Albert DH, Tapang P, Magoc TJ , et al.
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor.
Mol Cancer Ther 2006;
5 (4) 995-1006
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.